Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Novel Acinetobacter strain enables high-concentration biocatalysis for chiral acid production. Reduces cost and improves supply chain reliability for pharmaceutical intermediates.
Patent CN1729174B details a robust route to oxindole and indole derivatives, bypassing hazardous hydrazine steps for reliable API intermediate supply.
Patent CN103288685B details a high-purity synthesis route for 3-guanidino propanoic acid using ion exchange, offering significant cost reduction in pharmaceutical intermediates manufacturing.
Patent CN106478600A ensures 99.9% purity Lansoprazole. Stable crystal form A. Cost-effective supply chain solution for global pharmaceutical manufacturers seeking reliable partners.
Patent CN1272494A details a novel CD ring fragment synthesis. This report analyzes cost reduction in API manufacturing and supply chain reliability for pharmaceutical intermediates.
Novel low-temperature process for high-purity imiquimod intermediates using phthalimide protection, offering significant cost reduction and scalability for pharmaceutical manufacturing.
Patent CN104610218A reveals efficient L-proline catalyzed synthesis. Offers cost reduction and scalable supply for pharmaceutical intermediates manufacturing.
Novel synthetic route for beta-lactam antibiotic intermediates offers scalable production and substantial cost efficiency for global pharmaceutical supply chains.
Patent CN101723855B details a one-pot synthesis for Agomelatine intermediate. Offers high purity, reduced solvent use, and scalable manufacturing for reliable supply chains.
Patent CN109020987B details an iodine-mediated synthesis of chiral pyrazole spirofurans using squaric acid catalysts, offering high yield and selectivity for API manufacturing.
Patent CN1789247A details a high-yield stereospecific route for chiral N-acylpiperidines. Discover cost-effective manufacturing and scalable supply chain solutions for complex alkaloid intermediates.
Novel one-step refining for Topiramate ensures <0.1% impurities. Cost-effective, scalable pharmaceutical manufacturing solution for global supply chains.
Patent CN109553513B reveals a novel 2-step route for 4-(2-methoxyethyl)phenol, offering cost-effective API intermediate manufacturing.
Patent CN117326961A offers safer route avoiding cyanide. Reduces cost and improves supply chain reliability for pharmaceutical intermediates manufacturing globally.
Patent CN103772382A details a mild synthesis route for high-purity intermediates. This method offers significant supply chain reliability and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN102127021B details a novel solubilization method for bisbenzimidazole salts ensuring high purity and scalable manufacturing for global pharmaceutical supply chains.
Patent CN106983872A reveals a novel DHA-docetaxel conjugate synthesis improving solubility and reducing toxicity for scalable pharmaceutical intermediate manufacturing supply chains.
Patent CN108948114B enables high-purity 9-(E)-erythromycin oxime via novel biphasic impurity removal, ensuring cost reduction and supply chain reliability for global pharmaceutical manufacturers.
Advanced phase-transfer catalysis process for high-purity antiviral intermediates. Reduces steps and improves optical purity compared to enzymatic resolution methods.
Patent CN106631968A reveals a Pd-catalyzed route for indole derivatives, offering cost reduction and scalable manufacturing for pharmaceutical intermediates.